EPISODE · Jul 27, 2025 · 3 MIN
阿斯利康宣布旗下纳米抗体治疗重症肌无力新药 全面达标 - 250726
from 生物科技 · host Rei
阿斯利康重磅新药 Gefurulimab 三期临床全线达标，或将改写重症肌无力治疗格局！本期快讯带你快速了解这款纳米抗体药物的机制、优势及其对 Vyvgart 和 Zilbrysq 的潜在挑战。
Embed this episode
Ready to play
阿斯利康宣布旗下纳米抗体治疗重症肌无力新药 全面达标 - 250726
0:00
3:13
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 生物科技?
This episode is 3 minutes long.
When was this 生物科技 episode published?
This episode was published on July 27, 2025.
Can I download this 生物科技 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!